Loading...
A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease
OBJECTIVE: To evaluate the efficacy and safety of a selective serotonin reuptake inhibitor (SSRI) and a serotonin and norepinephrine reuptake inhibitor (SNRI) in the treatment of depression in Parkinson disease (PD). METHODS: A total of 115 subjects with PD were enrolled at 20 sites. Subjects were r...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Lippincott Williams & Wilkins
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3324323/ https://ncbi.nlm.nih.gov/pubmed/22496199 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0b013e3182516244 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|